Your browser doesn't support javascript.
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients.
Higgins, Peter D R; Ng, Siew; Danese, Silvio; Rao, Krishna.
  • Higgins PDR; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Ng S; Department of Internal Medicine, Chinese University of Hong Kong, Hong Kong, China.
  • Danese S; Department of Internal Medicine, Humanitas University, Milan, Italy.
  • Rao K; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Crohns Colitis 360 ; 2(2): otaa026, 2020 Apr.
Article in English | MEDLINE | ID: covidwho-60429
ABSTRACT
This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews Language: English Journal: Crohns Colitis 360 Year: 2020 Document Type: Article Affiliation country: Crocol

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews Language: English Journal: Crohns Colitis 360 Year: 2020 Document Type: Article Affiliation country: Crocol